– Reuters Citing NBC
Context Therapeutics Q2 EPS $(0.25)
Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.
Related Posts
Tesla’s ‘50% Growth Mirage’ Over, Says Bearish Analyst On Key Data Showing ‘Underwhelming’ Demand For Cybertruck, Refreshed Model 3
Gordon Johnson said Tesla's margins are collapsing and demand for its upcoming EVs is weak after a disappointing Q3.
XpresSpa Group Expands Retail Products For Women, Underscoring Company’s Commitment To Support Women’s Health And Wellness
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (NASDAQ:XSPA) ("XpresSpa" or the "Company"), a leader in health and wellness solutions for people on the go, has launched the
Biden Optimistic About Debt Ceiling Deal Ahead Of Key Tuesday Meeting, But Republicans Aren’t Buying It
The biggest catalyst for the SPDR S&P 500 ETF Trust (NYSE: SPY) in the next few weeks could easily be a U.S. debt ceiling deal between President Joe Biden and House Republicans.